Bullish
Patients dosed with Cabaletta’s rese-cel manufactured on Cellares’ Cell Shuttle
Cellares announced that the first two patients have been dosed with Cabaletta Bio's investigational CAR T cell therapy, rese-cel, manufactured using C...